CSat Investment Advisory’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-383
| Closed | -$56K | – | 539 |
|
|
2020
Q3 | $56K | Buy |
383
+32
| +9% | +$4.68K | 0.01% | 652 |
|
|
2020
Q2 | $52K | Buy |
351
+14
| +4% | +$2.07K | 0.01% | 671 |
|
|
2020
Q1 | $37K | Buy |
337
+42
| +14% | +$4.61K | 0.01% | 600 |
|
|
2019
Q4 | $34K | Buy |
295
+53
| +22% | +$6.11K | 0.01% | 665 |
|
|
2019
Q3 | $19K | Buy |
242
+24
| +11% | +$1.88K | 0.01% | 715 |
|
|
2019
Q2 | $16K | Buy |
+218
| New | +$16K | 0.01% | 729 |
|